Cart
sales@molnova.com
Ceftiofur
CAS No. 80370-57-6
Ceftiofur ( —— )
Catalog No. M21539 CAS No. 80370-57-6
Ceftiofur is a semisynthetic antibiotic with activity against various gram-positive/negative anaerobic and aerobic bacteria encountered by domestic animals.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 26 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCeftiofur
-
NoteResearch use only not for human use.
-
Brief DescriptionCeftiofur is a semisynthetic antibiotic with activity against various gram-positive/negative anaerobic and aerobic bacteria encountered by domestic animals.
-
DescriptionCeftiofur is a semisynthetic antibiotic with activity against various gram-positive/negative anaerobic and aerobic bacteria encountered by domestic animals.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80370-57-6
-
Formula Weight523.6
-
Molecular FormulaC19H17N5O7S3
-
Purity>98% (HPLC)
-
SolubilityDMSO:1 mg/mL (191. mM)
-
SMILESCO/N=C(\C(N[C@@H]([C@H]1SCC(CSC(c2ccco2)=O)=C(C(O)=O)N11)C1=O)=O)/c1csc(N)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fernández-Varón E et al. Pharmacokinetics (PK) pharmacodynamics (PD) and PK-PD integration of ceftiofur after a single intravenous subcutaneous and subcutaneous-LA administration in lactating goats. BMC Vet Res. 2016 Oct 13;12(1):232.
molnova catalog
related products
-
CHEMBL1276927
CHEMBL1276927 shows antibacterial and antiparasitic activities against Chlamydia pneumoniae and Leishmania donovani.
-
Rifamycin S
Rifamycin S is a potent DNA-dependent RNA polymerase inhibitoris a quinone and an antibiotic agnet against Gram-positive bacteria.
-
QcrB inhibitor TB47
QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M.
